Back to search
FDAFDA · Food and drugs·Recall number D-0827-2026

Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, Illinois, 60047, NDC 65219-594-20.

Published September 2, 2026 · Recall initiated: August 10, 2026

Summary

FDA records drug Class I recall D-0827-2026, published September 2, 2026 and initiated August 10, 2026. Recalling firm: Fresenius Kabi USA, LLC; Status: Ongoing; Reported quantity: 4,643 20mL-vials; Lot: Lot: 16UI07, Exp 08/31/2028. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email if TYENNE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TYENNE
Manufacturer
Fresenius Kabi USA, LLC
Distributor
Nationwide in the USA
Lot
Lot: 16UI07, Exp 08/31/2028
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, Illinois, 60047, NDC 65219-594-20. recalled?

Yes. FDA published recall D-0827-2026 on September 2, 2026. Reported hazard: Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TYENNE.